chalcone has been researched along with Arthritis, Degenerative in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chi, Q; Gao, Y; Liu, Y; Wang, C; Xu, K; Yang, L; Zhang, Z | 1 |
Feng, ZH; Fu, X; Hu, ZC; Li, XB; Ni, WF; Tang, Q; Wu, AM; Xie, ZJ; Xuan, JW | 1 |
2 other study(ies) available for chalcone and Arthritis, Degenerative
Article | Year |
---|---|
Safflower yellow alleviates osteoarthritis and prevents inflammation by inhibiting PGE2 release and regulating NF-κB/SIRT1/AMPK signaling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Chalcone; Chondrocytes; Dinoprostone; Gene Expression Regulation; Humans; Matrix Metalloproteinase 13; Molecular Docking Simulation; NF-kappa B; Osteoarthritis; Phosphatidylinositol 3-Kinases; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1 | 2020 |
Hydroxysafflor yellow A (HSYA) targets the NF-κB and MAPK pathways and ameliorates the development of osteoarthritis.
Topics: ADAMTS5 Protein; Animals; Chalcone; Cyclooxygenase 2; Dinoprostone; Humans; Interleukin-1beta; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Osteoarthritis; Quinones; Tumor Necrosis Factor-alpha | 2018 |